Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 14, 2019Journal of Experimental & Clinical Cancer ResearchOpen Access

PD-L1 expression and tumor mutational burden status for prediction of response to chemotherapy and targeted therapy in non-small cell lung cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

YCYanhui ChenGuangdong University of TechnologyQLQuanxing LiuArmy Medical UniversityZCZhiming ChenSoochow University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Chen et al. (2019) studied this question.

synapsesocial.com/papers/6a205d4d67e003a2985ade56https://doi.org/10.1186/s13046-019-1192-1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Clinical evaluation of compounds targeting PD-1/PD-L1 pathway for cancer immunotherapy2014 · 103 citations
  2. 2PD-L1 biomarker testing for non-small cell lung cancer: truth or fiction?2016 · 208 citations
  3. 3Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer2015 · 8,075 citations